Our research focuses on three areas:

  • Investigating the mechanisms, biomarkers and novel therapies for acute kidney injury
  • Studying the pathogenesis and biomarkers for focal segmental glomerulosclerosis
  • Identifying lupus nephritis molecular pathways and biomarkers

For each of these conditions, we employ an integrated approach of genomic and proteomic research using animal and human models. We then work to translate, validate and commercialize our findings.